Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

TILDENAFIL

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

135 API Suppliers, 28 USDMF, 27 CEP/COS, 8 JDMF, 24 EU WC, 39 KDMF, 40 NDC API, 62 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

68 Drugs in Development

68 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

909 FDF Dossiers, 130 FDA Orange Book, 504 Europe, 69 Canada, 35 Australia, 50 South Africa, 121 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG, TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG, TABLET;ORAL - 20MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 4 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 6 BASF, 10 Corel Pharma Chem, 5 DFE Pharma, 5 Gangwal Chemicals, 4 Ideal Cures, 1 Ingredion Pharma Solutions, 19 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 4 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Coating Systems & Additives, 31 Fillers, Diluents & Binders, 18 Granulation, 16 Controlled & Modified Release, 15 Direct Compression, 13 Lubricants & Glidants, 13 Disintegrants & Superdisintegrants, 10 Thickeners and Stabilizers, 9 Co-Processed Excipients, 7 Film Formers & Plasticizers, 6 Taste Masking, 5 Empty Capsules, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 3 Emulsifying Agents, 3 Rheology Modifiers, 3 API Stability Enhancers, 2 Coloring Agents, 1 Solubilizers, 1 Topical, 1 Parenteral, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

3 Data Compilation #PharmaFlow, 1 Stock Recap #PipelineProspector, 165 News #PharmaBuzz

GLOBAL SALES INFORMATION

29 US Medicaid Prescriptions, 27 Regulatory FDF Prices, 18 Annual Reports

MARKET PLACE

36 APIs, 7 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents, 26 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 14 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
31/03/2026	Century Pharmaceuticals	India	Hokem Trading Co., Ltd.	20250114-203-I-688-21	Tadarafil	2025-01-14	Century Pharmaceuticals Limited	India	103-106, GIDC, Halol City.- Halol – 389 350, Dist.- Panchmahal Gujarat State, India
31/03/2026	Evonik	Germany	Lilly Korea Ltd.	20211014-203-I-626-17	Tadarafil	2021-10-14	Evonik Corporation@Powdersize LLC	Germany	Tippecanoe Laboratories, 1650 Lilly Road Lafayette, Indiana 47909, USA_x000D_ _x000D_ @20 Pacific Drive Quakertown, Pennsylvania 18951 USA

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

TILDENAFIL

TILDENAFIL

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

135 API Suppliers

28 USDMF

27 CEP/COS

8 JDMF

24 EU WC

39 KDMF

40 NDC API

62 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

68 Drugs in Development

INTERMEDIATES

6 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

909 FDF Dossiers

130 FDA Orange Book

504 Europe

69 Canada

35 Australia

50 South Africa

121 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG

TABLET;ORAL - 2.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 20MG

TABLET;ORAL - 5MG

TABLET;ORAL - 20MG

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

4 Gangwal Healthcare

1 Nanjing Well Pharmaceutical

1 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

1 Aeon Procare

5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

6 BASF

10 Corel Pharma Chem

5 DFE Pharma

5 Gangwal Chemicals

4 Ideal Cures

1 Ingredion Pharma Solutions

19 Kerry

2 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

10 Microlex e.U

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

1 Novo Excipients

1 Pharmatrans-Sanaq

4 Pluviaendo

3 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

10 Roquette

6 Seppic

4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

10 Sigachi Industries

3 Silverline Chemicals

2 The Dow Chemical Company

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

39 Coating Systems & Additives

31 Fillers, Diluents & Binders

18 Granulation

16 Controlled & Modified Release

15 Direct Compression

13 Lubricants & Glidants

13 Disintegrants & Superdisintegrants

10 Thickeners and Stabilizers

9 Co-Processed Excipients

7 Film Formers & Plasticizers

6 Taste Masking

5 Empty Capsules

TABLET;ORAL - 2.5MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons